ASBP
Aspire Biopharma Holdings, Inc.
$7.97
+1.92%
2026-08-21
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Key Fundamentals
EPS (TTM)
$-7.09
ROE
-1032.1%
Profit Margin
0.0%
Debt/Equity
38.76
Price/Book
0.26
Beta
0.15
Market Cap
$10.2M
Avg Volume (10D)
32K
Recent Breakout Signals
No recent breakout signals detected for ASBP.
Recent Price Range (60 Days)
60D High
$8.20
60D Low
$4.45
Avg Volume
256K
Latest Close
$7.97
Get breakout alerts for ASBP
Sign up for Breakout Scanner to receive daily notifications when ASBP triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Aspire Biopharma Holdings, Inc. (ASBP) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors ASBP daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ASBP operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.